Join
Live feed
·
INSIDERFilingvia Quantisnow
Tenaya Therapeutics Inc. logo

Chief Executive Officer Ali Faraz sold $4,158 worth of shares (3,126 units at $1.33), decreasing direct ownership by 1% to 299,666 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNYA (Tenaya Therapeutics Inc.) and more on Quantisnow.